European rare blood disorder registry
Part of Blood & lymphatic, Cancer, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study is building a registry of people with rare blood diseases. By joining, you help doctors learn more about these conditions and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a rare blood disorder (as defined by the Orphanet classification).
- You are between 0 and 100 years old.
- You or your legal guardian can sign a consent form (if required by your country's rules).
- You do not have only a carrier trait for another recessive rare blood disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a European registry (database) to collect information about people with rare anemia disorders. By joining, you help researchers better understand these conditions and improve care for yourself and others.
This study is a registry (a large database) that collects information from people who have or may have a blood disorder. It helps researchers learn more about these conditions and improve care.
This study collects information from patients with Diamond Blackfan Anemia (DBA), a rare blood disorder that affects red blood cell production. By joining this registry, you help doctors better understand DBA and improve treatments for patients like you.
This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.
This study is a registry that collects information about people diagnosed with rare histiocytic disorders. It helps doctors better understand these conditions over time and may improve future care.
This study is a “registry,” meaning it collects information about adults with specific types of myeloproliferative neoplasms (MPNs). It helps researchers better understand these diseases and may improve future care.
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.